Physician profile
Hugh Nymeyer
NPI 1225560550
$6,036.07
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $435 · 2022: $1,929 · 2023: $2,194 · 2024: $1,478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,368 · Education: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,367.51 |
| Education | $304.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,251.12 | 2021-2024 | |
| Janssen Biotech, INC. | $890.61 | 2021-2024 | Tremfya |
| Sun Pharmaceutical Industries INC. | $824.38 | 2021-2024 | Ilumya |
| Pfizer INC. | $580.51 | 2022-2024 | |
| Lilly USA, LLC | $384.47 | 2021-2024 | Olumiant, Taltz |
| Novartis Pharmaceuticals Corporation | $353.64 | 2022-2024 | |
| Incyte Corporation | $267.63 | 2022-2024 | Opzelura |
| Amgen INC. | $260.52 | 2021-2024 | Otezla |
| Ucb, INC. | $232.31 | 2021-2024 | Cimzia, Bimzelx |
| Regeneron Healthcare Solutions, INC. | $206.88 | 2022-2024 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $204.16 | 2023-2024 | Sotyktu |
| Genzyme Corporation | $133.70 | 2022-2024 | |
| Organon LLC | $113.25 | 2024 | |
| Arcutis Biotherapeutics, INC. | $65.13 | 2024 | Zoryve |
| Janssen Scientific Affairs, LLC | $61.58 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.77 | 2023-2024 | Spevigo |
| Biofrontera INC. | $34.77 | 2021-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Galderma Laboratories, L.P. | $31.78 | 2022 | |
| Genentech USA, INC. | $26.97 | 2023 | Xolair |
| Teva Pharmaceuticals USA, INC. | $22.78 | 2024 | Simlandi |
| Verrica Pharmaceuticals INC. | $21.62 | 2023 | Ycanth |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugh Nymeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.